For example, PDL1 expression in CSCs protects from immune attack by braking the activation signaling pathways in anti-tumor effector cells, such as T cells and NK cells, via programmed cell death 1 (PD1) signaling [81,82]. Here, PDCD1 is linked to neoplasm.